Literature DB >> 18990450

IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes.

Myrianne Duré1, Fernando Macian.   

Abstract

T cell responses are determined by the environment in which antigen is encountered. In the absence of proper costimulation, anergizing stimuli induce the activation of a specific program of gene expression. Proteins encoded by these genes impose a state of functional unresponsiveness in anergic T cells through the activation of different mechanisms that include dampening of the T cell receptor signaling and direct inhibition of cytokine expression. Anergy can be reversed by stimulating T cells in the presence of interleukin (IL-)2. Signaling through the IL-2 receptor has been shown to activate mTOR, which plays an important role in the integration of signals that determine the fate of T cells. The mechanisms underlying the IL-2-dependent regulation of T cell tolerance are still not fully elucidated. In this study we show that IL-2 receptor signaling mediated through JAK3 and mTOR inhibits the expression of anergy-inducing genes independently of any effect on cell cycle progression. Interestingly, we also show that this effect is likely due to changes on the levels of AP-1 activation induced by IL-2 receptor signaling in T cells. Our data identifies a mechanism that can explain how IL-2 may prevent or reverse the establishment of anergy in T cells and, therefore, helps to understand how the cytokine environment can be determinant to shape the outcome of T cell responses - tolerance or activation - when antigen is encountered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18990450      PMCID: PMC2667138          DOI: 10.1016/j.molimm.2008.09.029

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  44 in total

1.  GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells.

Authors:  Niroshana Anandasabapathy; Gregory S Ford; Debra Bloom; Claire Holness; Violette Paragas; Christine Seroogy; Heidi Skrenta; Marie Hollenhorst; C Garrison Fathman; Luis Soares
Journal:  Immunity       Date:  2003-04       Impact factor: 31.745

Review 2.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  IL-2 and IL-15 manifest opposing effects on activation of nuclear factor of activated T cells.

Authors:  Donald M Eicher
Journal:  Cell Immunol       Date:  2003-06       Impact factor: 4.868

4.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

Authors:  Ken Inoki; Yong Li; Tian Xu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

5.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.

Authors:  Vigo Heissmeyer; Fernando Macián; Sin-Hyeog Im; Rajat Varma; Stefan Feske; K Venuprasad; Hua Gu; Yun-Cai Liu; Michael L Dustin; Anjana Rao
Journal:  Nat Immunol       Date:  2004-02-15       Impact factor: 25.606

6.  Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.

Authors:  Sam Collins; Michael A Lutz; Paul E Zarek; Robert A Anders; Gilbert J Kersh; Jonathan D Powell
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

7.  Two isoforms of otubain 1 regulate T cell anergy via GRAIL.

Authors:  Luis Soares; Christine Seroogy; Heidi Skrenta; Niroshana Anandasabapathy; Patricia Lovelace; Chan D Chung; Edgar Engleman; C Garrison Fathman
Journal:  Nat Immunol       Date:  2003-12-07       Impact factor: 25.606

8.  Interleukin-2, but not interleukin-15, is required to terminate experimentally induced clonal T-cell anergy.

Authors:  S Bendiksen; O P Rekvig
Journal:  Scand J Immunol       Date:  2004 Jul-Aug       Impact factor: 3.487

9.  The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction.

Authors:  Amy Allen; Yan Zheng; Lawrence Gardner; Meredith Safford; Maureen R Horton; Jonathan D Powell
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells.

Authors:  Christine M Seroogy; Luis Soares; Erik A Ranheim; Leon Su; Claire Holness; Debra Bloom; C Garrison Fathman
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

View more
  29 in total

Review 1.  The anti-DNA antibody: origin and impact, dogmas and controversies.

Authors:  Ole P Rekvig
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

2.  Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape.

Authors:  Sanmay Bandyopadhyay; Thomas J Quinn; Lisa Scandiuzzi; Indranil Basu; Ari Partanen; Wolfgang A Tomé; Fernando Macian; Chandan Guha
Journal:  J Immunol       Date:  2016-01-11       Impact factor: 5.422

Review 3.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

4.  Macroautophagy regulates energy metabolism during effector T cell activation.

Authors:  Vanessa M Hubbard; Rut Valdor; Bindi Patel; Rajat Singh; Ana Maria Cuervo; Fernando Macian
Journal:  J Immunol       Date:  2010-11-08       Impact factor: 5.422

5.  Cell cycle arrest caused by MEK/ERK signaling is a mechanism for suppressing growth of antigen-hyperstimulated effector T cells.

Authors:  Shizuka Ohtsuka; Shuhei Ogawa; Ei Wakamatsu; Ryo Abe
Journal:  Int Immunol       Date:  2016-08-19       Impact factor: 4.823

6.  Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells.

Authors:  Ian Baine; Samik Basu; Rachel Ames; Rani S Sellers; Fernando Macian
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

7.  Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.

Authors:  Shaun O'Brien; Rajan M Thomas; Gerald B Wertheim; Fuqin Zhang; Hao Shen; Andrew D Wells
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

Review 8.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

Review 9.  The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma.

Authors:  Antonio Romo de Vivar Chavez; Michael E de Vera; Xiaoyan Liang; Michael T Lotze
Journal:  Med Oncol       Date:  2009-01-16       Impact factor: 3.064

10.  Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Authors:  Nicholas M Provine; Rafael A Larocca; Malika Aid; Pablo Penaloza-MacMaster; Alexander Badamchi-Zadeh; Erica N Borducchi; Kathleen B Yates; Peter Abbink; Marinela Kirilova; David Ng'ang'a; Jonathan Bramson; W Nicholas Haining; Dan H Barouch
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.